
XBiotech (XBIT) Stock Forecast & Price Target
XBiotech (XBIT) Analyst Ratings
Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%
XBiotech (XBIT) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of XBiotech and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of XBiotech and is not a guaranteed prediction by Public.com or investment advice.
XBiotech (XBIT) Analyst Forecast & Price Prediction
Get the latest XBiotech (XBIT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in XBiotech (XBIT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About XBiotech (XBIT) Forecast
Analysts have given XBiotech (XBIT) a Buy based on their latest research and market trends.
According to 1 analysts, XBiotech (XBIT) has a Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $18, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.